If you’ve ever wondered which Indian firm started the country’s modern drug game, the answer points to Ranbaxy Laboratories. Founded in 1961 by the Singh brothers in Kolkata, Ranbaxy grew from a tiny lab to one of the biggest names in the global pharma arena. While a few smaller drug shops existed before the 1960s, Ranbaxy is the first Indian‑owned company that survived, expanded, and left a lasting footprint.
Why does this matter today? The company’s early focus on affordable antibiotics and generic medicines set a pattern that many newer players still follow. Understanding Ranbaxy’s origins helps you see how Indian pharma moved from local remedies to world‑class exports.
Back in 1961, the Singh brothers bought a small laboratory called Alkem Laboratories (not to be confused with today’s Alkem). Their goal was simple: produce quality medicines that Indian doctors could trust without relying on imports. Within a few years they launched their first brand‑name drug, an anti‑malaria tablet that became a household name across the country.
The early 1970s were all about building credibility. Ranbaxy earned its first ISO certification in 1978, proving that its processes met international standards. That move opened doors to export markets in Africa and the Middle East, where cheap, reliable generics were in high demand.
Fast forward to the 1990s, when India’s economic liberalisation kicked in. Ranbaxy seized the moment, invested heavily in R&D, and started filing patents for its own formulations. By the early 2000s the company was listed on the NYSE, making it the first Indian pharma to break into the US stock market.
Ranbaxy’s story isn’t just about a single brand; it’s a template for how Indian firms can compete globally. The company showed that with strict quality control, low‑cost production, and smart market entry, an Indian pharma can stand shoulder‑to‑shoulder with giants from the US and Europe.
Today, the legacy lives on through companies that grew out of Ranbaxy’s original network. Many of the staff, suppliers, and manufacturing practices have been absorbed by newer players like Sun Pharma and Cipla, who continue to push the affordable‑medicine agenda.
If you’re an entrepreneur eyeing the pharma sector, the Ranbaxy playbook offers three practical takeaways:
So, when you hear people talk about the "oldest pharma company in India," remember it’s more than a date—it’s a lesson in building trust, scaling smart, and staying relevant for decades.
Whether you’re a student, a budding pharma entrepreneur, or just curious about Indian industry history, the Ranbaxy journey offers clear, actionable insights. The next time you pick up a generic tablet, think about the decades of innovation that made it possible.
Dive into the fascinating history of India's oldest pharmaceutical company. This article explores the roots of the Indian pharma industry, highlighting the pioneering company that set the foundation. Along with insightful facts, discover how this company has evolved and tips for appreciating its contributions today.
Read More© 2025. All rights reserved.